Incorporated in 2013, Aether Industries Limited is a manufacturer of speciality chemicals. The company is the sole manufacturer in India of chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone and Bifenthrin Alcohol.
The company has three business models: Large scale manufacturing of intermediates and speciality chemicals, CRAMS (contract research and manufacturing services) and Contract manufacturing.
Aether Industries has two manufacturing sites at Sachin in Surat, Gujarat. Manufacturing Facility 1 is a 3,500 square metre facility including R&D and Hydrogenation Facilities and Pilot Plant. Manufacturing Facility 2 encompasses roughly 10,500 square metres, with an installed capacity of 6,096 MT per year spread among three buildings and 16 production streams as of September 30, 2021.
As of March 31, 2022, Aether Industries Limited's product portfolio comprised over 25 products which were sold to over 34 global companies in 18 countries and to over 154 domestic companies. The company is the largest manufacturer of 4MEP, T2E, NODG and HEEP products in the world by volume.
Differentiated portfolio of market-leading products.
Focus on R&D to leverage the core competencies of chemistry and technology.
Long-standing relationships with a diversified customer base.
Synergistic Business Models focused on Large Scale Manufacturing, CRAMS and Contract Manufacturing.
Focus on Quality, Environment, Health and Safety (QEHS).
Strong and consistent financial performance.
Experienced Promoters and Senior Management with extensive domain knowledge.
| Summary of financial Information (Restated Consolidated) | ||||
| Particulars | For the year/period ended (₹ in million) | |||
| 31-Dec-21 | 31-Dec-20 | 31-Mar-21 | 31-Mar-20 31-Mar-19 | |
| Total Assets | 7,095.61 | 4,000.95 | 4,529.44 3,004.67 2,066.75 | |
| Total Revenue | 4493.15 | 3,373.41 | 4,537.89 3,037.81 2,032.77 | |
| Profit After Tax | 829.06 | 482.54 | 711.19 399.56 233.35 | |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹610 to ₹642 per equity share |
| Market Lot | 23 Shares |
| Min Order Quantity | 23 Shares |
| Listing At | BSE, NSE |
| Issue Size | [.] Eq Shares of ₹10 (aggregating up to ₹808.04 Cr) |
| Fresh Issue | [.] Eq Shares of ₹10 (aggregating up to ₹627.00 Cr) |
| |
| IPO Open Date | May 24, 2022 |
| IPO Close Date | May 26, 2022 |
| Basis of Allotment Date | May 31, 2022 |
| Initiation of Refunds | June 01, 2022 |
| Credit of Shares to Demat Account | June 02, 2022 |
| IPO Listing Date | June 03, 2022 |
| BID LOT | 23 | 46 | 69 | 92 | 115 | 138 | 161 |
| AMOUNT | 14766 | 29,532 | 44298 | 59064 | 73830 | 88596 | 103,362 |
| BID LOT | 184 | 207 | 230 | 253 | 276 | 299 |
| AMOUNT | 118128 | 132894 | 147660 | 162426 | 177192 | 191958 |
Office Phone : 02792-220579
02792-232579
Mobile No. : (+91) 9429501579
Kapad Bazar, Nr Tower,
B/H Old Vegetable Market,
Amreli. (365601) Gujarat
Risk Factors – Investments in Mutual Funds are subject to Market Risks. Read all scheme related documents carefully before investing. Mutual Fund Schemes do not assure or guarantee any returns. Past performances of any Mutual Fund Scheme may or may not be sustained in future. There is no guarantee that the investment objective of any suggested scheme shall be achieved. All existing and prospective investors are advised to check and evaluate the Exit loads and other cost structure (TER) applicable at the time of making the investment before finalizing on any investment decision for Mutual Funds schemes. We deal in Regular Plans only for Mutual Fund Schemes and earn a Trailing Commission on client investments. Disclosure For Commission earnings is made to clients at the time of investments.
AMFI Registered Mutual Fund Distributor – ARN-156458 | Date of initial registration ARN – 16-Nov-2018 | Current validity of ARN – 01-Jan-2028
Grievance Officer- N.J.SECURITIES | gopalzinzu@gmail.com
Copyright 2024. N.J.Securities. Important Links | Disclaimer | Disclosure | Privacy Policy | SID/SAI/KIM | Code of Conduct | SEBI Circulars | AMFI Risk Factors